Hatfield, Pennsylvania-based CurveBeam LLC, specializing in weight-bearing CT (WBCT) imaging, has announced that its systems are now compatible with Exactech, Inc.’s Vantage® Ankle PSI.
CurveBeam System Now Compatible with Exactech Vantage Ankle PSI
Founded in 2009 by a team with advanced diagnostic imaging experience, CurveBeam focuses on orthopedic CT imaging. In 2012, CurveBeam introduced its first generation WBCT system. In 2020, CurveBeam received U.S. Food and Drug Administration (FDA) clearance for its third generation WBCT system, the HiRise.
Gainesville, Florida-based Exactech developed its Vantage Ankle PSI through a partnership with 3D Systems, Inc. According to the press release, “Vantage Ankle PSI is the only ankle system that accepts WBCT datasets of solely the foot and ankle region for pre-surgical planning and 3D-printing of patient-specific cutting guides.” Thanks to this collaboration, CurveBeam users can now present foot and ankle scans directly to the Vantage Ankle PSI.
The Vantage Ankle PSI received FDA clearance in November 2020. It is part of Exactech’s Active Intelligence® platform of smart technologies. According to the company, “the Vantage Ankle PSI 3D-printed tibia and talar cutting guides allow surgeons to pre-plan resections to align and cut in one step. Its soft tissue offsets are designed to preserve the periosteum while maintaining a reproducible fit.”
CurveBeam President and CEO Arun Singh told OTW, “This partnership further validates and confirms the applicability of WBCT for alignment assessment, a critical component for preoperative planning and postoperative success.”
Singh continued, “We continue to work tirelessly to make WBCT imaging the standard of care.”
Readers interested in the integration of the two systems can tune in to a web broadcast on May 25, 2021. The broadcast will feature orthopedic surgeon Mark Easley, M.D. Dr. Easley worked on the Vantage Ankle PSI design and currently uses the system in his preoperative planning. During the web broadcast, he will review cases in which CurveBeam WBCT scans were used with the Vantage Ankle PSI.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.